Annamaria Mascolo
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions 13
-
- Diabetes Treatment and Management 9
-
- Heart Failure Treatment and Management 6
- Pharmacology top 10%
- Drug-Induced Adverse Reactions 10
- Geriatrics and Gerontology top 10%
-
- Heparin-Induced Thrombocytopenia and Thrombosis 5
-
- COVID-19 Clinical Research Studies 5
-
- Pharmaceutical studies and practices 5
-
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Annalisa CapuanoCristina ScavoneLiberata SportielloMaurizio SessaConcetta RafanielloFrancesco RossiLiberato BerrinoGabriella di Mauro
- Partner nations
- ItalyDenmarkUnited Kingdom
In The Last Decade
Annamaria Mascolo
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 115
- Toxicology 203
- Endocrinology, Diabetes and Metabolism 231
- Cardiology and Cardiovascular Medicine 270
- Pharmacology 160
- Geriatrics and Gerontology 37
Countries citing papers authored by Annamaria Mascolo
This map shows the geographic impact of Annamaria Mascolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annamaria Mascolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annamaria Mascolo more than expected).
Fields of papers citing papers by Annamaria Mascolo
This network shows the impact of papers produced by Annamaria Mascolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annamaria Mascolo. The network helps show where Annamaria Mascolo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Annamaria Mascolo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 30 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 10 | |
| 7 | 2022 | 16 | |
| 8 | 2021 | 33 | |
| 9 | 2021 | 59 | |
| 10 | 2020 | 32 | |
| 11 | 2020 | 34 | |
| 12 | 2019 | 26 | |
| 13 | 2019 | 44 | |
| 14 | 2018 | 8 | |
| 15 | 2018 | 55 | |
| 16 | 2017 | 4 | |
| 17 | 2016 | 33 | |
| 18 | 2016 | 17 | |
| 19 | 2016 | 53 | |
| 20 | 1997 | 12 |
About Annamaria Mascolo
Annamaria Mascolo is a scholar working on Toxicology, Internal Medicine and Endocrinology, Diabetes and Metabolism, having authored 64 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (13 papers), Drug-Induced Adverse Reactions (10 papers), Diabetes Treatment and Management (9 papers), Heart Failure Treatment and Management (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (5 papers), COVID-19 Clinical Research Studies (5 papers), Pharmaceutical studies and practices (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Toxicology (203 citations), Endocrinology, Diabetes and Metabolism (231 citations) and Cardiology and Cardiovascular Medicine (270 citations). Annamaria Mascolo has collaborated with scholars based in Italy, Denmark and United Kingdom. Frequent co-authors include Annalisa Capuano, Cristina Scavone, Liberata Sportiello, Maurizio Sessa, Concetta Rafaniello, Francesco Rossi, Liberato Berrino, Gabriella di Mauro, Antonella De Angelis and Francesco Rossi. Their work appears in journals such as PLoS ONE, Scientific Reports and BMJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.